These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21167821)

  • 1. Chronic cerebral hypoperfusion in rats causes proteasome dysfunction and aggregation of ubiquitinated proteins.
    Hai J; Lin Q; Su SH; Zhang L; Wan JF; Lu Y
    Brain Res; 2011 Feb; 1374():73-81. PubMed ID: 21167821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-stearoyl-L-tyrosine on the hippocampal ubiquitin-proteasome system in rats with chronic cerebral hypoperfusion.
    Hai J; Lin Q; Wu YF; Huang XS; Zhang GY; Wang F
    Neurol Res; 2013 Sep; 35(7):734-43. PubMed ID: 23562289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes of signal transduction pathways in hippocampal regions and postsynaptic densities after chronic cerebral hypoperfusion in rats.
    Hai J; Yu F; Lin Q; Su SH
    Brain Res; 2012 Jan; 1429():9-17. PubMed ID: 22063366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein aggregation after focal brain ischemia and reperfusion.
    Hu BR; Janelidze S; Ginsberg MD; Busto R; Perez-Pinzon M; Sick TJ; Siesjö BK; Liu CL
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):865-75. PubMed ID: 11435799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model.
    Yao X; Liu J; McCabe JT
    J Neurochem; 2008 Jan; 104(2):353-63. PubMed ID: 17944870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures.
    Myeku N; Metcalfe MJ; Huang Q; Figueiredo-Pereira M
    Methods Mol Biol; 2011; 793():273-96. PubMed ID: 21913107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow and metabolic changes in hippocampal regions of a modified rat model with chronic cerebral hypoperfusion.
    Jian H; Yi-Fang W; Qi L; Xiao-Song H; Gui-Yun Z
    Acta Neurol Belg; 2013 Sep; 113(3):313-7. PubMed ID: 23111782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
    Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L
    J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition.
    Gavilán MP; Pintado C; Gavilán E; Jiménez S; Ríos RM; Vitorica J; Castaño A; Ruano D
    Aging Cell; 2009 Dec; 8(6):654-65. PubMed ID: 19747230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related differences in the dynamics of hippocampal proteasome recovery.
    Gavilán MP; Pintado C; Gavilán E; García-Cuervo LM; Castaño A; Ríos RM; Ruano D
    J Neurochem; 2012 Nov; 123(4):635-44. PubMed ID: 22913583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid peptide attenuates the proteasome activity in neuronal cells.
    Oh S; Hong HS; Hwang E; Sim HJ; Lee W; Shin SJ; Mook-Jung I
    Mech Ageing Dev; 2005 Dec; 126(12):1292-9. PubMed ID: 16153690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the ubiquitin-proteasome proteolysis system by amino acids and insulin involves the adenosine monophosphate-activated protein kinase and mammalian target of rapamycin pathways in rat hepatocytes.
    Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gaudichon C; Tomé D
    Amino Acids; 2011 Jul; 41(2):457-68. PubMed ID: 20957397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an experimental proteasome inhibitor on the cytoskeleton, cytosolic protein turnover, and induction in the neuronal cells in vitro.
    Csizmadia V; Raczynski A; Csizmadia E; Fedyk ER; Rottman J; Alden CL
    Neurotoxicology; 2008 Mar; 29(2):232-43. PubMed ID: 18155769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining ubiquitinated protein aggregates in tissue sections.
    Kaniuk NA; Brumell JH
    Methods Mol Biol; 2010; 648():175-82. PubMed ID: 20700712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane preconditioning induces neuroprotection by attenuating ubiquitin-conjugated protein aggregation in a mouse model of transient global cerebral ischemia.
    Zhang HP; Yuan LB; Zhao RN; Tong L; Ma R; Dong HL; Xiong L
    Anesth Analg; 2010 Aug; 111(2):506-14. PubMed ID: 20610552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the proteasome in fly models of neurodegeneration.
    Yeh CH; Jansen M; Schmidt-Glenewinkel T
    Methods Mol Biol; 2011; 793():149-65. PubMed ID: 21913099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.